The Vaccines Epidemiology Forecaster allows you to interactively assess assumptions about vaccine launch dates and the time taken to reach the current coverage of a particular vaccine group in a specified country in order to size the potential patient population a vaccine could reach.

QUESTIONS ANSWERED

  • What is the addressable market for vaccines in development, and how will that change over time?
  • What is the current coverage of a vaccine in a specific country?
  • What assumptions can I make for a new vaccine launch based on comparator products in a given country or region?

GEOGRAPHIES

  • Global, with additional granularity for the G7

EPIDEMIOLOGY

  • Patient population data by country or region and income status, with an algorithm to make extrapolations for missing data on vaccine coverage, based on similarities in GDP.

COVERAGE

  • Vaccine coverage includes: BCG, DTP, polio, hep B (birth dose), HPV, Japanese encephalitis, MCV, rota, yellow fever

DATA & FEATURES

  • Delivered as a stand-alone Excel model based on DRG’s gold-standard epidemiology for vaccine coverage.
  • G7 dashboard facilitates a more-granular analysis in the mature markets.
  • Options to incorporate additional primary or secondary data and customizable deliverables.
  • Access to DRG’s expert epidemiologists for bespoke support.

Table of contents

  • Emerging Vaccines - Epidemiology - Vaccines Epidemiology Forecaster
    • Introduction
      • Please Note:
      • Overview

Author(s): Nishant Kumar, MPH

Nishant is a senior epidemiologist and head of oncology within the epidemiology team at Decision Resources Group. He also covers some CNS diseases, including Alzheimer’s disease and dementia. His key interests are developing interactive patient flows, and modelling disease progression to forecast commercially relevant drug-treatable incident and prevalent populations. Nishant also spends a lot of time collaborating with clients to help answer more specific questions through custom work and consulting projects.

His qualifications include an MSc in Public Health with specialization in epidemiology and statistics from King’s College London, and a BSc in Medical Studies from the University of Birmingham.